Theriva Biologics, Inc.
TOVX
$0.4797
-$0.0199-3.98%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.16% | -49.91% | -47.34% | -51.55% | -49.38% |
| Total Receivables | -11.11% | 71.29% | 27.11% | 565.52% | 718.88% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -38.82% | -15.68% | -9.38% | -28.12% | -25.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -78.30% | -67.38% | -69.83% | -89.69% | -85.29% |
| Total Current Assets | -42.39% | -40.59% | -43.82% | -48.07% | -46.26% |
|
|
|||||
| Total Current Assets | -42.39% | -40.59% | -43.82% | -48.07% | -46.26% |
| Net Property, Plant & Equipment | -29.12% | -29.30% | -21.53% | -17.81% | -15.52% |
| Long-term Investments | -- | -- | -- | -73.94% | -0.78% |
| Goodwill | -- | -- | -- | -73.94% | -0.78% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.32% | -12.07% | -1.39% | -1.28% | -0.51% |
| Total Assets | -34.00% | -35.98% | -34.83% | -35.23% | -28.22% |
|
|
|||||
| Total Accounts Payable | -23.47% | 11.56% | -9.24% | 26.18% | 18.96% |
| Total Accrued Expenses | 8.29% | 0.00% | -26.45% | 53.94% | 46.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.54% | 9.09% | 15.21% | 10.79% | 11.33% |
| Total Finance Division Other Current Liabilities | 212.53% | 78.15% | 74.48% | -82.32% | -81.96% |
| Total Other Current Liabilities | 212.53% | 78.15% | 74.48% | -82.32% | -81.96% |
| Total Current Liabilities | 35.60% | 12.57% | -16.24% | -25.03% | -30.28% |
|
|
|||||
| Total Current Liabilities | 35.60% | 12.57% | -16.24% | -25.03% | -30.28% |
| Long-Term Debt | 845.91% | -43.21% | -34.67% | -39.22% | -0.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -43.65% | -39.46% | -33.05% | -31.00% | -27.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -12.04% | 7.73% | -2.84% | -1.25% | 6.27% |
| Total Liabilities | 14.08% | 4.92% | -12.39% | -16.68% | -15.57% |
|
|
|||||
| Common Stock & APIC | 2.57% | 2.59% | 2.60% | 1.01% | 0.82% |
| Retained Earnings | -7.89% | -8.29% | -8.78% | -7.41% | -6.44% |
| Treasury Stock & Other | 1.58% | -472.66% | 86.92% | -54.81% | -39.12% |
| Total Common Equity | -50.63% | -48.42% | -40.13% | -42.47% | -34.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -36.14% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -36.14% | 0.00% |
|
|
|||||
| Total Common Equity | -50.63% | -48.42% | -40.13% | -42.47% | -34.40% |
| Total Preferred Equity | -- | -- | -- | -36.14% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -54.58% | -51.97% | -43.86% | -42.11% | -32.54% |
|
|
|||||